181 related articles for article (PubMed ID: 1836810)
1. The use of long-acting gonadotropin-releasing hormone agonist (GnRH-a; decapeptyl) and gonadotropins versus short-acting GnRH-a (buserelin) and gonadotropins before and during ovarian stimulation for in vitro fertilization (IVF).
Gonen Y; Dirnfeld M; Goldman S; Koifman M; Abramovici H
J In Vitro Fert Embryo Transf; 1991 Oct; 8(5):254-9. PubMed ID: 1836810
[TBL] [Abstract][Full Text] [Related]
2. Ovarian response and pregnancy rates in in vitro fertilization, gamete intrafallopian transfer, and in vivo fertilization therapies after combined gonadotropin-releasing hormone agonist/human menopausal gonadotropin stimulation.
Lindner C; Braendle W; Lichtenberg V; Köhler S; Bettendorf G
Gynecol Obstet Invest; 1990; 29(2):140-4. PubMed ID: 2139861
[TBL] [Abstract][Full Text] [Related]
3. Suppression with gonadotropin-releasing hormone analogues prior to stimulation with gonadotropins: comparison of three protocols.
Lipitz S; Ben-Rafael Z; Dor J; Shalev J; Elenbogen A; Levran D; Serr DM; Mashiach S
Gynecol Obstet Invest; 1989; 28(1):31-4. PubMed ID: 2528497
[TBL] [Abstract][Full Text] [Related]
4. The impact of the refractory period to gonadotropin therapy in IVF-ET cycles post longacting gonadotropin-releasing hormone (GNRH) analogue.
Ashkenazi J; Goldman GA; Dicker D; Feldberg D; Shelef M; Goldman JA
Eur J Obstet Gynecol Reprod Biol; 1991 Mar; 39(1):37-40. PubMed ID: 1827627
[TBL] [Abstract][Full Text] [Related]
5. [Increased incidence of ovarian hyperstimulation syndrome following combined GnRH agonist/hMG therapy].
Lindner C; Braendle W; Köhler S; Bettendorf G
Geburtshilfe Frauenheilkd; 1989 Apr; 49(4):337-44. PubMed ID: 2525500
[TBL] [Abstract][Full Text] [Related]
6. Revisiting gonadotrophin-releasing hormone agonist protocols and management of poor ovarian responses to gonadotrophins.
Hugues JN; Cédrin Durnerin IC
Hum Reprod Update; 1998; 4(1):83-101. PubMed ID: 9622415
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of different ovarian stimulation protocols for in vitro fertilization.
Pados G; Tarlatzis BC; Bontis J; Lagos S; Papadimas J; Spanos E; Mantalenakis S
Gynecol Endocrinol; 1995 Jun; 9(2):103-12. PubMed ID: 7502685
[TBL] [Abstract][Full Text] [Related]
8. Gonadotropin-releasing hormone agonist reduces the miscarriage rate for pregnancies achieved in women with polycystic ovarian syndrome.
Homburg R; Levy T; Berkovitz D; Farchi J; Feldberg D; Ashkenazi J; Ben-Rafael Z
Fertil Steril; 1993 Mar; 59(3):527-31. PubMed ID: 8458452
[TBL] [Abstract][Full Text] [Related]
9. Good results of milder form of ovarian stimulation in an in vitro fertilization/intracytoplasmic sperm injection program.
Grochowski D; Wołczyński S; Kuczyński W; Domitrz J; Szamatowicz J; Szamatowicz M
Gynecol Endocrinol; 1999 Oct; 13(5):297-304. PubMed ID: 10599545
[TBL] [Abstract][Full Text] [Related]
10. Comparison of ovarian stimulation regimens for in vitro fertilization (IVE) with and without a gonadotropin-releasing hormone (GnRH) agonist: results of a randomized study.
van de-Helder AB; Helmerhorst FM; Blankhart A; Brand R; Waegemaekers C; Naaktgeboren N
J In Vitro Fert Embryo Transf; 1990 Dec; 7(6):358-62; discussion 363-4. PubMed ID: 2127604
[TBL] [Abstract][Full Text] [Related]
11. The impact of HCG in IVF Treatment: Does it depend on age or on protocol?
Theofanakis C; Athanasiou V; Liokari E; Stavrou S; Sakellariou M; Athanassiou AI; Athanassiou A; Drakakis P; Loutradis D
J Gynecol Obstet Hum Reprod; 2019 May; 48(5):341-345. PubMed ID: 30794953
[TBL] [Abstract][Full Text] [Related]
12. Ultrashort gonadotropin-releasing hormone agonist (GnRH-a) protocol in comparison with the long-acting GnRH-a protocol and menotropin alone.
Ron-El R; Herman A; Golan A; Soffer Y; Nachum H; Caspi E
Fertil Steril; 1992 Dec; 58(6):1164-8. PubMed ID: 1459267
[TBL] [Abstract][Full Text] [Related]
13. Pregnancy rate and ovarian hyperstimulation after luteal human chorionic gonadotropin in in vitro fertilization stimulated with gonadotropin-releasing hormone analog and menotropins.
Herman A; Ron-El R; Golan A; Raziel A; Soffer Y; Caspi E
Fertil Steril; 1990 Jan; 53(1):92-6. PubMed ID: 2104811
[TBL] [Abstract][Full Text] [Related]
14. Ovarian stimulation concomitant with pituitary-ovarian axis suppression by different GnRH agonists.
Insler V; Lunenfeld E; Potashnik G; Levy J
Int J Fertil; 1991; 36(2):121-7. PubMed ID: 1674933
[TBL] [Abstract][Full Text] [Related]
15. Combination of long and short term GnRH analogue protocols: a new therapeutic approach to persistent high progesterone levels in IVF cycles.
Dicker D; Goldman GA; Ashkenazi J; Feldberg D; Shelef M; Goldman JA
Hum Reprod; 1991 Feb; 6(2):203-5. PubMed ID: 1829091
[TBL] [Abstract][Full Text] [Related]
16. Prospective randomized study of human menotropin versus a follicular and a luteal phase gonadotropin-releasing hormone analog-human menotropin stimulation protocols for in vitro fertilization.
Maroulis GB; Emery M; Verkauf BS; Saphier A; Bernhisel M; Yeko TR
Fertil Steril; 1991 Jun; 55(6):1157-64. PubMed ID: 1903732
[TBL] [Abstract][Full Text] [Related]
17. Do the suppression criteria in GnRH-a cycles predict in vitro fertilization outcome?
Senöz S; Gülekli B; Turhan NO; Ozakşit G; Odabaşi AR; Oral H; Ozcan U; Gökmen O
Gynecol Endocrinol; 1995 Jun; 9(2):91-6. PubMed ID: 7502695
[TBL] [Abstract][Full Text] [Related]
18. Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates.
Biljan MM; Mahutte NG; Dean N; Hemmings R; Bissonnette F; Tan SL
Fertil Steril; 1998 Dec; 70(6):1063-9. PubMed ID: 9848296
[TBL] [Abstract][Full Text] [Related]
19. The long protocol of administration of gonadotropin-releasing hormone agonist is superior to the short protocol for ovarian stimulation for in vitro fertilization.
Tan SL; Kingsland C; Campbell S; Mills C; Bradfield J; Alexander N; Yovich J; Jacobs HS
Fertil Steril; 1992 Apr; 57(4):810-4. PubMed ID: 1555692
[TBL] [Abstract][Full Text] [Related]
20. A randomized prospective study on the effect of short and long buserelin treatment in women with repeated unsuccessful in vitro fertilization (IVF) cycles due to inadequate ovarian response.
Dirnfeld M; Gonen Y; Lissak A; Goldman S; Koifman M; Sorokin Y; Abramovici H
J In Vitro Fert Embryo Transf; 1991 Dec; 8(6):339-43. PubMed ID: 1770275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
